This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 115/3/353    most recent CIRCULATIONAHA.106.657379v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morritt, A. N. Articles by Morrison, W. A. Search for Related Content PubMed PubMed Citation Articles by Morritt, A. N. Articles by Morrison, W. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL Related Collections Angiogenesis Myogenesis

(Circulation. 2007;115:353-360.)
© 2007 American Heart Association, Inc.

Molecular Cardiology

Cardiac Tissue Engineering in an In Vivo Vascularized Chamber

Andrew N. Morritt, MBChB, MRCS; Susan K. Bortolotto, PhD; Rodney J. Dilley, PhD; XiaoLian Han, BSc; Andrew R. Kompa, PhD; David McCombe, MD, FRACS; Christine E. Wright, PhD; Silviu Itescu, MBBS; James A. Angus, PhD; Wayne A. Morrison, MD, FRACS

From the Bernard O’Brien Institute of Microsurgery (A.N.M., S.K.B., X.L.H., D.M., W.A.M.); Departments of Surgery (A.N.M., D.M., W.A.M.) and Medicine (R.J.D., A.R.K., S.I.), St Vincent’s Hospital, University of Melbourne; and Cardiovascular Therapeutics Unit (C.E.W., J.A.A.), Department of Pharmacology, University of Melbourne, Melbourne, Australia.

Correspondence to Dr Rodney J. Dilley, Bernard O’Brien Institute of Microsurgery, 42 Fitzroy St, Fitzroy, 3065 Victoria, Australia. E-mail rdilley{at}medstv.unimelb.edu.au

Received August 10, 2006; accepted November 2, 2006.

Background— Cardiac tissue engineering offers the prospect of a novel treatment for acquired or congenital heart defects. We have created vascularized pieces of beating cardiac muscle in the rat that are as thick as the adult rat right ventricle wall.

Method and Results— Neonatal rat cardiomyocytes in Matrigel were implanted with an arteriovenous blood vessel loop into a 0.5-mL patented tissue-engineering chamber, located subcutaneously in the groin. Chambers were harvested 1, 4, and 10 weeks after insertion. At 4 and 10 weeks, all constructs that grew in the chambers contracted spontaneously. Immunostaining for -sarcomeric actin, troponin, and desmin showed that differentiated cardiomyocytes present in tissue at all time points formed a network of interconnected cells within a collagenous extracellular matrix. Constructs at 4 and 10 weeks were extensively vascularized. The maximum thickness of cardiac tissue generated was 1983 µm. Cardiomyocytes increased in size from 1 to 10 weeks and were positive for the proliferation markers Ki67 and PCNA. Connexin-43 stain indicated that gap junctions were present between cardiomyocytes at 4 and 10 weeks. Echocardiograms performed between 4 and 10 weeks showed that the tissue construct contracted spontaneously in vivo. In vitro organ bath experiments showed a typical cardiac muscle length-tension relationship, the ability to be paced from electrical field pulses up to 3 Hz, positive chronotropy to norepinephrine, and positive inotropy in response to calcium.

Conclusion— In summary, the use of a vascularized tissue-engineering chamber allowed generation of a spontaneously beating 3-dimensional mass of cardiac tissue from neonatal rat cardiomyocytes. Further development of this vascularized model will increase the potential of cardiac tissue engineering to provide suitable replacement tissues for acquired and congenital defects.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				E. I. Chang, R. G. Bonillas, S. El-ftesi, E. I. Chang, D. J. Ceradini, I. N. Vial, D. A. Chan, J. Michaels V, and G. C. Gurtner Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds FASEB J, March 1, 2009; 23(3): 906 - 915. [Abstract] [Full Text] [PDF]

				P. Akhyari, H. Kamiya, A. Haverich, M. Karck, and A. Lichtenberg Myocardial tissue engineering: the extracellular matrix. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 229 - 241. [Abstract] [Full Text] [PDF]

				Y. Yildirim, H. Naito, M. Didie, B. C. Karikkineth, D. Biermann, T. Eschenhagen, and W.-H. Zimmermann Development of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model Circulation, September 11, 2007; 116(11_suppl): I-16 - I-23. [Abstract] [Full Text] [PDF]